Ion Exchange (500214) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
10 Jul, 2026Vision and business overview
Aims to be a leader in vital environmental solutions, focusing on water and sustainability.
Over 61 years of presence, operating in 23 countries with 7 manufacturing facilities in India and 4 overseas.
Offers total water and environment management solutions for industry, homes, and communities.
Holds over 50 patents and has commercialized 100+ products, with strong R&D and application centers.
Executed more than 150,000 projects globally, with a robust service and sales network.
Market and industry landscape
Global water and wastewater treatment market projected to grow at 7.5% CAGR, reaching USD 536.41 Bn by 2030.
Indian water and wastewater treatment market valued at INR 199 Bn, with significant municipal and industrial segments.
Only 60% of industrial wastewater is treated in India, creating growth opportunities.
Government initiatives like 'Har Ghar Nal se Jal' and 'Namami Gange' drive sector expansion.
Water treatment chemicals market expected to grow rapidly, with Asia Pacific holding 33% share.
Business segments and operations
Engineering (61% of revenue): Designs, constructs, and maintains water and wastewater plants for diverse sectors.
Chemicals (29%): Manufactures water treatment chemicals, ion exchange resins, and specialty chemicals.
Consumer Products (10%): Provides RO and other water purification solutions for homes, institutions, and rural markets.
Strong order book of INR 22,500 Mn in engineering, with a significant bid pipeline.
Exports account for 35% of revenue, with a presence in key global markets.
Latest events from Ion Exchange
- FY25 revenue up 16.6% YoY to INR 27,371 Mn; dividend of ₹1.50 and Roha plant to drive growth.500214
Q4 24/2510 Jul 2026 - Revenue up but margins and profits down due to costs and Labour Codes; SEBI case ongoing.500214
Q3 25/2610 Jul 2026 - Strong revenue and profit growth, with margin pressure from legacy contract and robust order book.500214
Q3 24/2510 Jul 2026 - FY26 revenue rose 6.5% but net profit dropped 31% as margins and costs weighed on results.500214
Q4 25/2610 Jul 2026 - Strong revenue and profit growth, margin expansion, and robust order pipeline; SEBI litigation risk.500214
Q2 24/2510 Jul 2026 - Q2 FY26 revenue grew 13.9% YoY, but margins declined and SEBI litigation remains a risk.500214
Q2 25/2610 Jul 2026 - Q1 FY26 delivered higher revenue and profit, with Roha plant commissioning and SEBI matter ongoing.500214
Q1 25/2610 Jul 2026 - Q1 FY25 saw double-digit growth, strong order book, and ongoing regulatory challenges.500214
Q1 24/2510 Jul 2026